Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer

Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have been reported in the literature. We report a recent case in our institution, a 23-year-old female-to-male tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristina Ferreira, João Fraga, Célia Antunes, Manuela Gonçalo, Paulo Donato
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Case Reports in Radiology
Online Access:http://dx.doi.org/10.1155/2021/8861692
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560612354293760
author Cristina Ferreira
João Fraga
Célia Antunes
Manuela Gonçalo
Paulo Donato
author_facet Cristina Ferreira
João Fraga
Célia Antunes
Manuela Gonçalo
Paulo Donato
author_sort Cristina Ferreira
collection DOAJ
description Ovarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have been reported in the literature. We report a recent case in our institution, a 23-year-old female-to-male transsexual patient who received testosterone supplementation. The patient underwent a pelvic magnetic resonance imaging to study an ovarian complex cyst that revealed the presence of a bilateral ovarian tumor with imaging features of borderline serous tumor. These masses were surgically removed and the pathology report confirmed the diagnosis associated with noninvasive peritoneal implants and the presence of numerous androgen receptors in the tumor cells. Although there is still insufficient data to validate a direct correlation between hormonotherapy and ovarian cancer in these patients, this case may reinforce previous reports on this association and highlights the relevance of radiological follow-up and bilateral salpingo-oophorectomy as part of gender reassignment surgery.
format Article
id doaj-art-9d656fad45f2455e8c89b45c3a2fafee
institution Kabale University
issn 2090-6862
2090-6870
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Case Reports in Radiology
spelling doaj-art-9d656fad45f2455e8c89b45c3a2fafee2025-02-03T01:27:06ZengWileyCase Reports in Radiology2090-68622090-68702021-01-01202110.1155/2021/88616928861692Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian CancerCristina Ferreira0João Fraga1Célia Antunes2Manuela Gonçalo3Paulo Donato4Department of Radiology, University Centre Hospitals of Coimbra (CHUC), 3000-075 Coimbra, PortugalDepartment of Pathology, University Centre Hospitals of Coimbra (CHUC), 3000-075 Coimbra, PortugalDepartment of Radiology, University Centre Hospitals of Coimbra (CHUC), 3000-075 Coimbra, PortugalDepartment of Radiology, University Centre Hospitals of Coimbra (CHUC), 3000-075 Coimbra, PortugalDepartment of Radiology, University Centre Hospitals of Coimbra (CHUC), 3000-075 Coimbra, PortugalOvarian cancer is the most fatal gynecologic malignancy. The incidence of ovarian cancer among female-to-male transsexuals receiving treatment with testosterone is unknown, and few cases have been reported in the literature. We report a recent case in our institution, a 23-year-old female-to-male transsexual patient who received testosterone supplementation. The patient underwent a pelvic magnetic resonance imaging to study an ovarian complex cyst that revealed the presence of a bilateral ovarian tumor with imaging features of borderline serous tumor. These masses were surgically removed and the pathology report confirmed the diagnosis associated with noninvasive peritoneal implants and the presence of numerous androgen receptors in the tumor cells. Although there is still insufficient data to validate a direct correlation between hormonotherapy and ovarian cancer in these patients, this case may reinforce previous reports on this association and highlights the relevance of radiological follow-up and bilateral salpingo-oophorectomy as part of gender reassignment surgery.http://dx.doi.org/10.1155/2021/8861692
spellingShingle Cristina Ferreira
João Fraga
Célia Antunes
Manuela Gonçalo
Paulo Donato
Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
Case Reports in Radiology
title Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
title_full Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
title_fullStr Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
title_full_unstemmed Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
title_short Serous Borderline Tumor in Transgender Female-to-Male Individuals: A Case Report of Androgen Receptor-Positive Ovarian Cancer
title_sort serous borderline tumor in transgender female to male individuals a case report of androgen receptor positive ovarian cancer
url http://dx.doi.org/10.1155/2021/8861692
work_keys_str_mv AT cristinaferreira serousborderlinetumorintransgenderfemaletomaleindividualsacasereportofandrogenreceptorpositiveovariancancer
AT joaofraga serousborderlinetumorintransgenderfemaletomaleindividualsacasereportofandrogenreceptorpositiveovariancancer
AT celiaantunes serousborderlinetumorintransgenderfemaletomaleindividualsacasereportofandrogenreceptorpositiveovariancancer
AT manuelagoncalo serousborderlinetumorintransgenderfemaletomaleindividualsacasereportofandrogenreceptorpositiveovariancancer
AT paulodonato serousborderlinetumorintransgenderfemaletomaleindividualsacasereportofandrogenreceptorpositiveovariancancer